Healthcare Services

De-identified health data market developments (2026–2030)

April 21, 2026April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The De-Identified Health Data Market Be By 2030 Compared To Its 2026 Market Size?

The market size for de-identified health data has experienced rapid growth in recent years. It is projected to expand from $9.2 billion in 2025 to $10.31 billion in 2026, at a compound annual growth rate (CAGR) of 12.1%. Historically, this growth can be attributed to the increasing adoption of electronic health records, a rising demand for population health analytics, the expansion of clinical research databases, a growing focus on patient privacy compliance, and the increasing availability of structured healthcare data.

The de-identified health data market size is projected to experience swift expansion over the coming years. This market is predicted to reach $16.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 11.7%. Key factors driving this growth during the forecast period include the expanding application of AI-driven health insights, increasing investments in precision medicine research, the growth of value-based care analytics, a heightened need for secure health data exchange, and the broader acceptance of real-world evidence in regulatory decision-making. Significant trends anticipated within this period encompass the development of large-scale de-identified data platforms, increasing utilization of real-world evidence analytics, a growing preference for privacy-preserving data sharing models, greater incorporation of longitudinal patient data analysis, and the amalgamation of multi-source healthcare datasets.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/de-identified-health-data-global-market-report

What Major Factors Are Driving The De-Identified Health Data Market Forward?

The expanding uptake of electronic health records (EHRs) is projected to boost the growth of the de-identified health data market in the future. Electronic health records (EHR) represent a digital compilation of a patient’s full medical history, covering diagnoses, treatments, medications, lab results, and other health data, which is securely stored and shared among authorized healthcare providers. The widespread use of EHRs is increasing because they improve patient care and safety by providing precise, real-time access to complete medical information. De-identified health data improves electronic health records by facilitating secure data sharing and sophisticated analytics while safeguarding patient privacy, ultimately leading to better clinical decisions and health outcomes. As an illustration, in August 2025, the National Center for Biotechnology Information, a US-based National Library of Medicine (NLM) and a component of the U.S. National Institutes of Health (NIH), a federal government agency, indicated in 2024 that the majority of hospitals had implemented patient engagement features allowing patients to electronically view (99%) (e.g., test results), download (96%), and transmit their health information to a third party (84%). Consequently, the growing acceptance of electronic health records (EHRs) is fueling the expansion of the de-identified health data market.

Which Segment Classifications Are Used In The De-Identified Health Data Market Segment Analysis?

The de-identified health data market covered in this report is segmented –

1) By Type: Clinical Data, Genomic Data, Patient Demographics, Prescription Data, Hospital And Provider Data, Pharmacogenomic Data

2) By Application: Clinical Research And Trials, Public Health, Precision Medicine, Health Economics And Outcomes Research (HEOR), Population Health Management, Drug Discovery And Development, Healthcare Quality Improvement, Insurance Underwriting And Risk Assessment, Other Applications

3) By End-User: Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Insurance Companies Or Healthcare Payers, Research Institutions, Government Agencies, Other End-Users

Subsegments:

1) By Clinical Data: Electronic Health Records, Medical Imaging Data, Laboratory Test Results, Surgical Reports, Pathology Reports, Vital Signs Measurements

2) By Genomic Data: Whole Genome Sequencing Data, Exome Sequencing Data, Single Nucleotide Polymorphism Data, Gene Expression Profiles, Epigenetic Data

3) By Patient Demographics: Age Information, Gender Information, Ethnicity Information, Geographic Location, Socioeconomic Status, Marital Status

4) By Prescription Data: Medication Orders, Dosage Information, Prescription Refill History, Drug Allergies, Pharmacy Dispensation Records

5) By Hospital And Provider Data: Provider Performance Metrics, Care Delivery Outcomes, Billing And Claims Data, Resource Utilization Data

6) By Pharmacogenomic Data: Gene–Drug Interaction Data, Adverse Drug Reaction Data, Personalized Therapy Response Data, Drug Efficacy Variation Data

Which Trends Are Impacting The Progress Of The De-Identified Health Data Market?

Major companies operating in the de-identified health data market are concentrating on developing advanced solutions, such as real-world biomarker coverage applications, to bolster evidence-based healthcare decision-making. Such an application harnesses de-identified patient data to track and evaluate biomarker patterns and efficacy across varied populations outside clinical trials, furnishing researchers and healthcare providers with insights into treatment responses and disease trends. For instance, in July 2025, Datma Inc., a US-based healthcare technology company, is set to launch the Federated Biomarker Explorer, a free application tailored for pharmaceutical teams to rapidly confirm real-world biomarker coverage throughout Datma’s federated network of participating data contributors. This tool offers aggregate, cohort-level insights into biomarker presence, enabling teams to assess coverage swiftly without requiring contracts or IT support. Furthermore, it permits secure integration of users’ own data for overlap analysis and aids early-stage feasibility assessments through clinical and demographic filtering, thereby assisting in validating whether datasets encompass the necessary patient populations before committing resources.

Which Firms Are Contributing To The De-Identified Health Data Market Ecosystem?

Major companies operating in the de-identified health data market are UnitedHealth Group Incorporated, Oracle Corporation, IQVIA Holdings Inc, ICON Public Limited Company, Datavant Inc, Premier Inc., iMerit Technology Services Pvt. Ltd., Tempus Labs Inc., Medidata Solutions Inc., Veradigm Inc., Flatiron Health, Merative LP, Komodo Health Inc., Shaip Inc., Truveta Inc., Evidation Health Inc., TriNetX Inc., Clarify Health Solutions Inc., Akrivia Health Ltd., Gradient Health Inc.

Get The Full De-Identified Health Data Market Report:

https://www.thebusinessresearchcompany.com/report/de-identified-health-data-global-market-report

Which Region Represents The Largest Share Of The De-Identified Health Data Market?

North America was the largest region in the de-identified health data market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the de-identified health data market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized De-Identified Health Data Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/de-identified-health-data-global-market-report

Browse Through More Reports Similar to the Global De-Identified Health Data Market 2026, By The Business Research Company

Genomics Personalized Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

Healthcare Data Integration Market Report 2026

https://www.thebusinessresearchcompany.com/report/healthcare-data-integration-global-market-report

Personal Health Record Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/personal-health-record-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795